Investors get testy in April, delays IPO for Durham pharma Scynexis

Durham pharmaceutical company Scynexis again switched up the terms of its initial public offering, this time pegging the price per share at $10 and looking to raise $64 million...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.